Market Place
Sourcing Support
Study Confirms Nerivio REN Safe with CGM Devices in Migraine
25 Feb 2026 //
PHARMIWEB
Theranica Nerivio REN Shows Steady Drug-Free Migraine Relief Care
12 Nov 2025 //
PR NEWSWIRE
Theranica to Present Real-World Evidence Studies at AHS Meeting
19 Jun 2025 //
GLOBENEWSWIRE
Theranica`s Nerivio REN gets coverage from 2nd largest U.S. Insurer
22 Apr 2025 //
GLOBENEWSWIRE
Largest Insurer in Publishes Positive Reimbursement for Nerivio
05 Feb 2025 //
GLOBENEWSWIRE
Colorado Medicaid To Cover Nerivio REN Wearable For Migraine Treatment
10 Jul 2024 //
PR NEWSWIRE
New Study Found Preventive Impact in Adolescents Who Frequently Used Nerivio
28 Nov 2023 //
PR NEWSWIRE
Theranica Enters Into Agreement With Dr. Reddy`s for Commercializing Nerivio
14 Nov 2023 //
PR NEWSWIRE
Theranica`s Nerivio® Cleared by FDA for Preventive Treatment of Migraine
28 Feb 2023 //
PR NEWSWIRE
Theranica partners with Dr Reddy`s for marketing wearable Nerivio in India
11 Jan 2023 //
ECONOMIC TIMES
Pennsylvania-based Highmark Joins Theranica`s Coverage with Evidence Program
12 Dec 2022 //
PRNEWSWIRE
Theranica aims to stretch FDA nod for migraine treatment armband
18 Oct 2022 //
FIERCEBIOTECH
New Study Suggests REN Comparable to Standard Care Prescribed Medications
19 Sep 2022 //
PRNEWSWIRE
Theranica ropes in $45M for smartphone-connected migraine modulation armband
30 Aug 2022 //
FIERCEBIOTECH
Theranica Secures $45 Million Series C Funding Round
29 Aug 2022 //
PRNEWSWIRE
MC-Rx Formalizes Pharmacy Benefit Coverage for Theranica`s Nerivio
04 Oct 2021 //
PRNEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.